HomeCompareBRLAF vs CL

BRLAF vs CL: Dividend Comparison 2026

BRLAF yields 6.64% · CL yields 2.43%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CL wins by $18.3K in total portfolio value· pulled ahead in Year 3
10 years
BRLAF
BRLAF
● Live price
6.64%
Share price
$4.61
Annual div
$0.31
5Y div CAGR
-27.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.5K
Annual income
$30.03
Full BRLAF calculator →
CL
CL
● Live price
2.43%
Share price
$85.73
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$5,401.96
Full CL calculator →

Portfolio growth — BRLAF vs CL

📍 CL pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBRLAFCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BRLAF + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BRLAF pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BRLAF
Annual income on $10K today (after 15% tax)
$564.74/yr
After 10yr DRIP, annual income (after tax)
$25.53/yr
CL
Annual income on $10K today (after 15% tax)
$206.23/yr
After 10yr DRIP, annual income (after tax)
$4,591.67/yr
At 15% tax rate, CL beats the other by $4,566.14/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BRLAF + CL for your $10,000?

BRLAF: 50%CL: 50%
100% CL50/50100% BRLAF
Portfolio after 10yr
$31.7K
Annual income
$2,716.00/yr
Blended yield
8.58%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

BRLAF
Analyst Ratings
1
Buy
1
Hold
Consensus: Buy
Altman Z
1.5
Piotroski
3/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+7.8% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BRLAF buys
0
CL buys
0
No recent congressional trades found for BRLAF or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBRLAFCL
Forward yield6.64%2.43%
Annual dividend / share$0.31$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-27.6%28.6%
Portfolio after 10y$22.5K$40.8K
Annual income after 10y$30.03$5,401.96
Total dividends collected$1.8K$18.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold

Year-by-year: BRLAF vs CL ($10,000, DRIP)

YearBRLAF PortfolioBRLAF Income/yrCL PortfolioCL Income/yrGap
1$11,181$481.03$11,012$312.01+$169.00BRLAF
2$12,328$363.92$12,196$412.95+$132.00BRLAF
3← crossover$13,462$271.49$13,599$549.66$137.00CL
4$14,605$200.61$15,288$736.64$683.00CL
5$15,775$147.26$17,353$995.28$1.6KCL
6$16,986$107.62$19,926$1,357.80$2.9KCL
7$18,254$78.42$23,194$1,873.82$4.9KCL
8$19,589$57.02$27,439$2,621.52$7.8KCL
9$21,001$41.40$33,088$3,727.38$12.1KCL
10$22,501$30.03$40,806$5,401.96$18.3KCL

BRLAF vs CL: Complete Analysis 2026

BRLAFStock

Our portfolio of high quality UK commercial property is focused on London Offices and Retail around the UK. We own or manage a portfolio valued at £13.7bn (British Land share: £10.3bn) as at 30 September 2020 making us one of Europe's largest listed real estate investment companies. Our strategy is to provide places which meet the needs of our customers and respond to changing lifestyles - Places People Prefer. We do this by creating great environments both inside and outside our buildings and use our scale and placemaking skills to enhance and enliven them. This expands their appeal to a broader range of occupiers, creating enduring demand and driving sustainable, long term performance. Our Offices portfolio comprises three office-led campuses in central London as well as high quality standalone buildings and accounts for 65% of our portfolio. Our Retail portfolio is focused on retail parks and shopping centres, and accounts for 31% of our portfolio. Increasingly our focus is on providing a mix of uses and this is most evident at Canada Water, our 53 acre redevelopment opportunity where we have plans to create a new neighbourhood for London. Sustainability is embedded throughout our business. Our places, which are designed to meet high sustainability standards, become part of local communities, provide opportunities for skills development and employment and promote wellbeing. In April 2016 British Land received the Queen's Award for Enterprise: Sustainable Development, the UK's highest accolade for business success for economic, social and environmental achievements over a period of five years.

Full BRLAF Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this BRLAF vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BRLAF vs SCHDBRLAF vs JEPIBRLAF vs OBRLAF vs KOBRLAF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.